Interim Management Statement

RNS Number : 1678K

Oryx International Growth Fund Ld

16 August 2012

 

ORYX INTERNATIONAL GROWTH FUND LIMITED

 INTERIM MANAGEMENT STATEMENT FOR THE QUARTER ENDED 30 JUNE 2012

 Oryx International Growth Fund Limited ("Oryx" or the "Company"), is publishing this Interim Management Statement in accordance with DTR 4.3 of the FSA Handbook.

 This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 This interim management statement relates to the period from 1 April 2012 to 30 June 2012, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 Manager's Review

During the period under review, the FTSE Small Cap TR (£) Index returned -4.24% and the FTSE All-Share TR Index (£) returned -2.63%. Against this, the Fund's net asset value decreased by 4.5% to 292p per share.

 The Manager anticipates that a number of the holdings within the Company's portfolio will benefit from corporate activity during the next twelve months.

 Material Transactions

Since 1 April 2012, the Company has purchased for cancellation the following shares:

 24 April 2012 a total of 379,653 ordinary shares at a gross price of £2.10 per share.

Material Events

There were no material events during the quarter ended 30 June 2012.

 Report and Accounts

On 15 June 2012, the Company posted its Annual Report and Accounts for the year ended 31 March 2012, to Shareholders.

Financial Highlights

	30 June 2012	31 March 2012	31 December 2011	30 September 2011	30 June 2011
NAV	£2.93	£3.03	£2.79	£2.69	£2.96
US Dollar / Sterling Exchange Rate	1.5685	1.5978	1.5541	1.5579	1.6055

Twenty Largest Equity Investments at 30 June 2012

	% Net Assets
Cvs Group Plc	7.85
Bioquell Plc	6.84
Gleeson (M.J.) Group Plc	6.67
Guinness Peat Group Plc	6.36
Orthoproducts Ltd	4.99
Augean Plc	4.96
Journey Group Plc	4.29
Eckoh Plc	4.28
Quarto Group Inc	4.26
Catalyst Media Group Plc	4.14
Assetco Plc	3.80
Innovation Group Plc	3.76
Sinclair Is Pharma Plc	3.23
Rpc Group Plc	2.75
Nastor Inv Ltd Zero Redeem Prefer Shares	2.61
Mecom Group Plc	2.42
Bionostics Holdings Ltd	2.40
Celsis Ag	2.09
Bavaria Industriekapital Ag	2.09
Sinav Limited	1.99
	81.78

The financial information for the quarter ended 30 June 2012 contained within this Interim Management Statement has not been audited.

By order of the Board

BNP Paribas Fund Services (Guernsey) Limited, for and on behalf of

Oryx International Growth Fund Limited

as Company Secretary

 

END

 

 

IMSGGUCPRUPPGUQ